Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Cambrex to Expand Its Edinburgh Screening Facility
Cambrex corporation announced plans to expand its facility in Edinburgh, Scotland, doubling the current footprint to 15,000 square feet
Pfizer Invests US$500 million For Gene Therapy Facility Expansion
Pfizer has announced its plans to invest US$500 million to construct a stateoftheart gene therapy manufacturing facility in Sanford, North Carolina
Fujifilm Irvine Plans New Manufacturing Facility in Europe
Fujifilm Irvine Scientific announced plans to build a new manufacturing facility to accelerate the development in bioproduction, and cell and gene therapy markets in Tilburg, Netherlands
Lonza Expands its Manufacturing Capabilities at Tampa Site
Lonza announced the completion of the expansion of US$15 million multiphase solid oral dose development and manufacturing capabilities at its Tampa, FL USA site
Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem
Mapi Pharma has signed a long term lease agreement at the HarHotzvim HiTech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products
Colorcon Plans to Build a New Starch Manufacturing Unit
Colorcon announced its plans to build a new starch manufacturing unit in Amsterdam, Netherlands This new facility is planned to double the existing manufacturing capacity for Starch 1500, Pregelatinised Maize Starch, supporting the continued growth of Colorcons excipient business across the world
Kite Announces Plans to Build a New Manufacturing Industry
Kite announces plans to build industryleading cell therapy manufacturing capabilities with a new viral vector facility in Oceanside, California
Lonza Announces to Expand HPAPI Development and Manufacturing Capacity
Lonza announced an expansion of Highly Potent API HPAPI capabilities from development to commercial scale manufacturing, including formulation and delivery
Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners
Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility A 100,000 square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation, or CDMO
Aldevron Breaks Ground to Build 14-Acre Gene Therapy Manufacturing Campus
Aldevron announces its plans to build 14acre gene therapy manufacturing campus at its headquarters in Fargo
